ITMCTR2022000019尚未招募早期 1 期
Efficacy evaluation and mechanism study of Yiqi Huashi and Jiedu Tongluo methods in chronic liver disease
试验速览
- 阶段
- 早期 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70（—）
- 性别
- All
入选标准
- •(1) Meet the diagnostic criteria for chronic hepatitis B;
- •(2) Meet the diagnostic criteria for liver fibrosis;
- •(3) Comply with the syndrome differentiation standard of Ganyu and Pixu;
- •(4) The age is between 18-70 years old, and the gender is not limited;
- •(5) Willing to participate in this research and sign the informed consent.
排除标准
- •(1) Patients with fibrosis caused by other causes of chronic liver disease;
- •(2) Acute and chronic hepatitis with non-HBV hepadnavirus infection, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hereditary Metabolic liver disease, drug or toxic hepatitis, alcoholic liver disease patients;
- •(3) pregnant or lactating women and women who plan to be pregnant during the study period;
- •(4) those who are allergic to the test drug;
- •(5) can not cooperate with mental disorders Patients in this study, or patients with unstable epilepsy;
- •(6) Patients with systemic diseases such as severe heart, brain, lung, kidney, and hematopoiesis;
- •(7) Alcoholism or other unsuitable drug test observers, or In combination with treatment, it is difficult to make a definitive evaluation of the effectiveness and safety of the drug;
- •(8) Other circumstances that the investigator believes are not suitable for enrollment.
研究者
相似试验
招募中
1 期
Clinical study of Shugan Jianpi Huazhi Decoction combined with Tongluo Yanggan application in the treatment of non-alcoholic fatty liver diseaseITMCTR2022000098Guang'anmen Hospital, China Academy of Chinese Medical Sciences
招募中
1 期
Clinical study of Jianpi Yanggan Decoction combined with Tongluo Yanggan application in the treatment of autoimmune hepatitisAutoimmune HepatitisITMCTR2022000094Guang'anmen Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
Clinical study of Qinggan Huashi Jiejiu Decoction combined with Tongluo Yanggan application in the treatment of alcoholic liver diseaseITMCTR2022000106Guang'anmen Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003080Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
招募中
1 期
Study on the clinical efficacy of Yiqi Huoxue Jiedu formula in the treatment of platinum resistant ovarian cancer based on the phenotypic changes of macrophagesovarian cancerITMCTR2100005211Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine